Building "Bridges" Across the Bayou City!
Houston Mayor Sylvester Turner has proposed a pay raise for firefighters, the latest in an ongoing issue.
Turner’s proposal, announced May 19, would give Houston firefighters a 6% raise for three consecutive years beginning on July 1, 2021.
That is …
Read MoreOn Thursday’s Houston Matters: We check in with the National Weather Service on the possibility of more severe weather this week and flash flooding this weekend. We also talk with News 88.7’s Jen Rice about Mayor Sylvester Turner’s proposal for increas…
Read MoreA local developer of software for the energy- and commodity-trading industry nabbed new growth funding.
Houston-based Molecule announced the close of a $12 million Series A funding round on May 6. Molecule develops cloud-based software offerings for …
Read MoreCart.com offers a range of e-commerce software products and services, including offerings for online storefronts, digital marketing, payment processing and more.
Read MoreIn the Christian Bible, the Story of the Nativity mentions the Three Kings. And in the Holy Book of the Blues there is another troika of monikered monarchs: the Kings named B.B., Albert, and Freddie. Contemporary blues singer/guitarist Chris Cain was f…
Read MoreSyzygy Plasmonic’s technology was spun out of Rice University and invented by co-founders and professors Naomi Halas and Peter Nordlander.
Read MoreHighRadius reached unicorn status — a coveted title given to private firms valued at over $1 billion — in early 2020 after raising a $125 million Series B round.
Read MoreAlthough it might consider combining with a business in any industry, Landcadia Holdings IV plans to focus on investment opportunities in the consumer, dining, hospitality, entertainment and gaming industries, including technology companies in these in…
Read MoreThe company develops custom software for enterprise clients in oil and gas, health care, supply chain, e-commerce and a variety of blue-collar sectors.
Read MoreIterion Therapeutics is investigating its lead clinical candidate, Tegavivint, in a Phase 1/2a clinical trial in patients with desmoid turmors.
Read More